Search

everythinglearnresearchcommunity

for

Search:↓

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

JAK inhibitors offer new hope for treating severe alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Apremilast did not work for treating severe alopecia areata.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

New cytokine-targeted therapies show promise for treating alopecia areata.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.